About This Fund
The Go Red for Women Venture Fund is a $75 million impact venture capital fund managed by AHA Ventures, the investment arm of the American Heart Association (AHA), dedicated to accelerating market solutions that address the cardiovascular, brain, and related health needs of women. Seeded with $40 million in direct capital from the American Heart Association and supported by a $15 million cornerstone gift, the fund represents one of the world's largest venture vehicles specifically focused on women's health, responding to the acute market gap where only 2 percent of the $41 billion in global healthcare venture capital deployed in 2023 targeted conditions affecting women.
The fund invests in companies developing products and services that recognize the unique physiological and clinical dimensions of women's health, spanning cardiovascular disease, brain health, digital health platforms, medical devices, health services, and diagnostics. The American Heart Association's century of accumulated expertise in science, medicine, and healthcare delivery provides a distinctive strategic asset for portfolio companies seeking clinical validation and evidence-based differentiation. The fund commenced its first investments in late 2024, with Neura Health receiving an $11.4 million Series A round as the fund's inaugural investment, followed by a strategic investment in Ultromics in December 2025.
By April 2025, the fund had raised approximately $60 million toward its $75 million target, drawing institutional and philanthropic commitments aligned with the women's health impact thesis. The fund's economic rationale is supported by research estimating that each dollar invested in women's health generates $3 in economic growth, pointing to a potential $1 trillion global economic uplift by 2040. The Go Red for Women initiative, which underpins the fund's brand and donor community, has been the American Heart Association's signature women's health movement for over two decades.